ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 329515 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 329515; 2) Community: the network communities that were significantly associated with the response to NSC 329515; 3) Molecule: the relationships between components within communities and NSC 329515; 4) MDR: the compounds that were significantly associated with the NSC 329515.

NSC Compound Enrichment Correlation
NSC 113908 Null 0.0392716453377535 0.245178
NSC 131257 Null 0.0392716453377535 0.2755846
NSC 163062 TRIPTOLIDE 0.0392716453377535 0.25243488
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0392716453377535 0.2099553
NSC 368891 Null 0.0392716453377535 0.45327389
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0392716453377535 0.019243759
NSC 58905 9H-Purine, 9-(2-chloroethyl)-6-[(phenylmethyl)thio]- (9CI) 0.0392716453377535 0.33042196
NSC 603624 Null 0.0392716453377535 0.32335493
NSC 610456 Camptothecin Derivative 0.0392716453377535 0.30037058
NSC 612223 Null 0.0392716453377535 0.30660761
Total:74  Current:57    [First] [Prev] [Next] [Last]